ホーム > 鈴木裕之/ Suzuki, Hiroyuki

鈴木裕之

ALUMNI 2025年11月現在、筑波大学が主たる所属機関ではありません

Suzuki, Hiroyuki

東北大学 , 大学院医学系研究科 , 准教授
Tohoku University , Graduate School of Medicine , Associate Professor

http://www.md.tsukuba.ac.jp/epatho/

http://www.md.tsukuba.ac.jp/younginit/

オープンアクセス版の論文は「つくばリポジトリ」で読むことができます。

21. A Cancer-Specific Anti-Podoplanin Monoclonal Antibody, PMab-117-mG2a Exerts Antitumor Activities in Human Tumor Xenograft Models Tomohiro Tanaka; Hiroyuki Suzuki; Tomokazu Ohishi; Mika K. KanekoYukinari Kato
Cells 13: 1833 (2024) Semantic Scholar
22. A Cancer-Specific Anti-Podoplanin Monoclonal Antibody, PMab-117-mG2a Exerts Antitumor Activities in Human Tumor Xenograft Models. Tomohiro Tanaka; Hiroyuki Suzuki; Tomokazu Ohishi; Mika K KanekoYukinari Kato
Cells 13: (2024) Semantic Scholar
23. Antitumor activities of anti‑CD44 monoclonal antibodies in mouse xenograft models of esophageal cancer Kenichiro Ishikawa; Hiroyuki Suzuki; Tomokazu Ohishi; Takuro Nakamura (+7 著者) Yukinari Kato
Oncology Reports 52: (2024) Semantic Scholar
24. Anti-CD44 Variant 10 Monoclonal Antibody Exerts Antitumor Activity in Mouse Xenograft Models of Oral Squamous Cell Carcinomas Kenichiro Ishikawa; Hiroyuki Suzuki; Tomokazu Ohishi; Guanjie Li (+5 著者) Yukinari Kato
International Journal of Molecular Sciences 25: 9190 (2024) Semantic Scholar
25. Anti-HER2 Cancer-Specific mAb, H2Mab-250-hG1, Possesses Higher Complement-Dependent Cytotoxicity than Trastuzumab. Hiroyuki Suzuki; Tomokazu Ohishi; Tomohiro Tanaka; Mika K KanekoYukinari Kato
International journal of molecular sciences 25: (2024) Semantic Scholar
26. Development of Sensitive Anti-Mouse CCR5 Monoclonal Antibodies Using the N-Terminal Peptide Immunization. Rena Ubukata; Hiroyuki Suzuki; Tomohiro Tanaka; Guanjie Li (+1 著者) Yukinari Kato
Monoclonal antibodies in immunodiagnosis and immunotherapy (2024) Semantic Scholar
27. Development of a Sensitive Anti-Mouse CCR5 Monoclonal Antibody for Flow Cytometry. Hiroyuki Suzuki; Tomohiro Tanaka; Guanjie Li; Tsunenori Ouchida (+1 著者) Yukinari Kato
Monoclonal antibodies in immunodiagnosis and immunotherapy (2024) Semantic Scholar
28. Epitope Mapping of an Anti-CD44v4 Monoclonal Antibody (C₄₄Mab-108) Using Enzyme-Linked Immunosorbent Assay Hiroyuki Suzuki; Mayuki Tawara; Aoi Hirayama; Nohara Goto (+2 著者) Yukinari Kato
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 43: 85 (2024)
29. Cx1Mab-1: A Novel Anti-mouse CXCR1 Monoclonal Antibody for Flow Cytometry. Guanjie Li; Tomohiro Tanaka; Tsunenori Ouchida; Mika K Kaneko (+1 著者) Yukinari Kato
Monoclonal antibodies in immunodiagnosis and immunotherapy 43: 59 (2024) Semantic Scholar
30. PMab-314: An Anti-Giant Panda Podoplanin Monoclonal Antibody. Tsunenori Ouchida; Guanjie Li; Hiroyuki Suzuki; Miyuki Yanaka (+4 著者) Yukinari Kato
Monoclonal antibodies in immunodiagnosis and immunotherapy 43: 53 (2024) Semantic Scholar
31. Epitope Mapping of an Anti-Mouse CD39 Monoclonal Antibody Using PA Scanning and RIEDL Scanning. Yuki Okada; Hiroyuki Suzuki; Tomohiro Tanaka; Mika K KanekoYukinari Kato
Monoclonal antibodies in immunodiagnosis and immunotherapy (2024) Semantic Scholar
32. Cx3Mab-4: A Novel Anti-Mouse CXCR3 Monoclonal Antibody for Flow Cytometry. Tsunenori Ouchida; Yu Isoda; Tomohiro Tanaka; Mika K Kaneko (+1 著者) Yukinari Kato
Monoclonal antibodies in immunodiagnosis and immunotherapy (2024)
33. Glycoprotein nonmetastatic melanoma protein B impacts the malignant potential of bladder cancer cells through its hem-immunoreceptor tyrosine-based activation motif. Tomokazu Kimura; Yukari Okita; Yoshiyuki Nagumo; Jas Min Chin (+6 著者) Mitsuyasu Kato
Pathology international (2024) Semantic Scholar
34. Locally misfolded HER2 expressed on cancer cells is a promising target for development of cancer-specific antibodies Takao Arimori; Emiko Mihara; Hiroyuki Suzuki; Tomokazu Ohishi (+3 著者) Yukinari Kato
Structure (2024) Semantic Scholar
35. A Cancer-Specific Monoclonal Antibody against HER2 Exerts Antitumor Activities in Human Breast Cancer Xenograft Models. Mika K Kaneko; Hiroyuki Suzuki; Tomokazu Ohishi; Takuro Nakamura (+1 著者) Yukinari Kato
International journal of molecular sciences 25: (2024) Semantic Scholar
36. Development of a Sensitive Anti-Mouse CD39 Monoclonal Antibody (C39Mab-1) for Flow Cytometry and Western Blot Analyses. Yuki Okada; Hiroyuki Suzuki; Mika K Kaneko; Yukinari Kato
Monoclonal antibodies in immunodiagnosis and immunotherapy 43: 24 (2024) Semantic Scholar
37. Establishment of Anti-Dog Programmed Cell Death Ligand 1 Monoclonal Antibodies for Immunohistochemistry. Tsunenori Ouchida; Hiroyuki Suzuki; Tomohiro Tanaka; Mika K KanekoYukinari Kato
Monoclonal antibodies in immunodiagnosis and immunotherapy (2024) Semantic Scholar
38. Establishment of a Novel Cancer-Specific Anti-HER2 Monoclonal Antibody H2Mab-250/H2CasMab-2 for Breast Cancers Mika K Kaneko; Hiroyuki Suzuki; Tomokazu Ohishi; Tomohiro TanakaYukinari Kato
(2023)
39. Establishment of a Novel Anti-mouse CCR1 Monoclonal Antibody C₁Mab-6 Tsunenori Ouchida; Yu Isoda; Tomohiro Tanaka; Mika K. Kaneko (+1 著者) Yukinari Kato
(2023)
40. A Cancer-Specific Monoclonal Antibody against Podocalyxin Exerted Antitumor Activities in Pancreatic Cancer Xenografts Hiroyuki Suzuki; Tomokazu Ohishi; Tomohiro Tanaka; Mika K. KanekoYukinari Kato
International Journal of Molecular Sciences 25: 161 (2023) Semantic Scholar

« 1 2 3 4 … 10 »

1. あなたのラボから薬を生み出すアカデミア創薬の実践 : all Japan体制の先端技術支援を利用した創薬の最前線善光, 龍哉; 辻川, 和丈 (担当:分担執筆, 範囲:CBIS法による高感度抗体の作製)
羊土社 2024年2月 (ISBN: 9784758104166)
2. がんゲノム医療時代の分子腫瘍学鈴木裕之; 後藤のはら; 加藤光保 (担当:分担執筆, 範囲:TGF-β経路)
文光堂 2022年4月
3. 炎症メディエーター TGF-β 鈴木,裕之; 青山,知恵; 加藤,光保 (担当:共著)
日本臨床 2009年5月
4. TGF-betaシグナル伝達系とがん治療鈴木裕之; 中条友香; 加藤光保 (担当:監修)
南山堂 2008年9月
5. TGF-βシグナル伝達とがん治療鈴木裕之; 中条友香; 加藤光保 (担当:分担執筆)
がんの分子標的治療 2008年6月
6. Negative regulation of the TGF-β family signal pathway by inhibitory Smads and their involvement in cancer and fibrosis. Itoh S; Suzuki H; Itoh F; Miyazono K; Kato M (担当:共著)
Humana Press Inc. 2008年
7. IGFBP 鈴木裕之; 加藤光保 (担当:監修)
サイトカイン・増殖因子用語ライブラリー / 羊土社 2005年3月
8. TGF-betaシグナルと疾患鈴木裕之; 宮園浩平 (担当:監修)
シグナル伝達研究2003 シグナル伝達研究2003 羊土社 2003年1月

1. THG-1 overexpression stabilizes β-catenin via antagonizing NRBP1 in esophageal squamous cell carcinoma Hwang, Jongchan; Suzuki, Hiroyuki; Zhang, Jing; Vasudevan, Prasanna; Dijke, Peter ten; Kato, Mitsuyasu
第79回日本癌学会学術総会 2020年10月1日
2. THG-1/TSC22D4による細胞老化の制御鈴木裕之; 加藤光保
第79回日本癌学会学術総会 2020年10月1日
3. THG-1はHIF-1alphaの安定化を介して腫瘍の進行を促進する鄭齢; 加藤, 光保; 鈴木裕之
第3回がん三次元培養研究会 2019年11月18日
4. Regulation of c-MYC transcriptional activity by transforming growth factor-beta 1–stimulated clone 22 Suzuki, SHiroyuki; Kato, Mitsuyasu
第78回日本癌学会学術総会 2019年9月26日
5. Screening of macrocyclic peptide against CD44 Goto, Nohara; HIPOLITO; CHRISTOPHER; Suzuki, Hiroyuki; Kato, Mitsuyasu
第78回日本癌学会学術総会 2019年9月26日
6. Oncogenic functions of TGFβ-stimulated clone-22 families
STINT Special Symposium on the Sweden-Japan 150 Anniversary Grant 2019年1月19日招待有り
7. Screening of macrocyclic peptide against CD44s Goto, Nohara; Yin, Yizhen; Hipolito, Christopher John; Suzuki, Hiroyuki; Suga, Hiroaki; Kato, Mitsuyasu; Heldin, Paraskevi; Constantinos Kolliopoulos; Karalis, Theodoros
第10回国際ペプチドシンポジウム／第55回ペプチド討論会 2018年12月3日
8. THG-1, a novel oncogene in tumor angiogenesis Zheng, Ling; Suzuki, Hiroyuki; Kato, Mitsuyasu
第41回日本分子生物学会年会 2018年11月28日
9. 乳がん細胞におけるGPNMBの幹細胞性誘導作用沖田結花里; 陳晨; 鈴木裕之; 加藤, 光保
第77回日本癌学会学術総会 2018年9月27日
10. 扁平上皮がん進展におけるTHG-1/Tsc22D4の機能鈴木裕之; 加藤, 光保
第77回日本癌学会学術総会 2018年9月27日
11. 3D imaging analysis of the promotion process from beta -catenin accumulated crypts to colonic adenomas in mice model Kase, Kazuo; Saito, Nobuko; Iwasaki, Hideaki; Hiroshima, Kenzo; Okita, Yukari; Watanabe, Yukihide; Suzuki, Hiroyuki; Kato, Mitsuyasu
日本癌学会学術総会 2018年9月27日
12. Roles of the interaction between THG-1 and NRBP1 in the development of esophageal squamous cell carcinoma Hwang, Jongchan; Miura, Mayuka; Suzuki, Hiroyuki; Djike, Peter ten; Kato, Mitsuyasu
Tsukuba Global Science Week 2018 2018年9月20日
13. 扁平上皮がんの発生病理鈴木裕之
第104回日本病理学会総会 2016年招待有り
14. Roles of THG-1/Tsc22D4 in squamous cell carcinoma development Hiroyuki Suzuki
Tsukuba-UCI Science Partnership Conference 2015年12月10日
15. Roles of THG-1/Tsc22D4 in squamous cell carcinoma development Hiroyuki Suzuki
Joint International Symposium on TGF-family and Cancer 2015年1月12日招待有り
16. Hypoxia and oxidative stress resistance in squamous cell carcinoma Hiroyuki Suzuki
Annual meeting of Hypoxia 2014年11月22日招待有り
17. Roles of THG-1/Tsc22D4 in tumor development Hiroyuki Suzuki
TGF-beta meeting, Netherland 2014 2014年5月9日
18. Roles of THG-1/Tsc22D4 in tumorigenesis Hiroyuki Suzuki
TGF-beta meeting, Sweden, 2013 2013年
19. TGF-β suppresses transcription of HO-1 gene through induction of MafK and Bach1. Yukari,Okita; Hiroyuki,Suzuki; Mitsuyasu,Kato
Leading Graduate Schools International Conference 2010年11月1日
20. Tsc-22 and TMEPAI; target genes of TGF-beta signaling possibly involved in cancer development Kato, M; Suzuki, H; Watanabe.Y; Itoh.S
*EMPTY*____ 2007年9月